Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04984356
Title A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Wugen, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | NLD | FRA | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Moffit Cancer Center Tampa Florida 33612 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Vanderbilt University Nashville Tennessee 37212 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
Peter MacCallum Cancer Centre Melbourne Victoria Australia Details
Hospital Saint- Louis Paris France Details
University Hospital Robert Debre Paris France Details
Erasmus MC Rotterdam Netherlands Details
Prinses Maxima Centrum Utrecht Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field